Skip to content

REtrospective study for Safety and Efficacy of Anti-Rheumatic treatment with biologiCs (RESEARCh)

REtrospective study for Safety and Efficacy of Anti-Rheumatic treatment with biologiCs (RESEARCh)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000096
Enrollment
458
Registered
2011-02-17
Start date
2011-01-11
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hanyang University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: rheumatoid arthritis patients who are over 18 years old, satisfy the 1987 classification criteria for RA of American college of Rheumatology and had treated with biologic agents or are currently using biologic agents

Exclusion criteria

Exclusion criteria: no exclusion criteria

Design outcomes

Primary

MeasureTime frame
treatment persistency

Secondary

MeasureTime frame
adverse event of drug

Countries

Korea, Republic of

Contacts

Public ContactYoon-Kyoung Sung

Clinical Research Center for Rheumatois Arthritis

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026